The correlation between high Cldn1 expression and poor overall survival further underscores its potential role as a prognostic marker in PDAC, which is consistent with studies in other cancer types where Cldn1 has been associated with tumor aggressiveness and metastasis [42,43,44,45,46,47]. This evidence concerns the gene CLDN1 and neoplasm.